-
Building trust between AI and medicine in oncology.
#INFORM: “Interpretability of Deep Neural Networks for Radiomics” CHIST-ERA ERA-NET project, coordinated by BIOEMTECH presents how #XAI (explainable artificial Intelligence) can boost early diagnosis and therapy prediction in radiation oncology. -
Our latest publication on “Novel in vivo micro-CT Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease” is now available online.
A rewarding collaboration with Antonios Chatzigeorgiou, Anna Hadjihambi and Rallia Velliou. Whenever setting up a new procedure at BIOEMTECH Labs, we always consult JoVE as a gold-standard basis of precise workflows, so it is of great honor and pleasure... -
The dates have been set! BIOEMTECH’s 3rd Preclinical Models Imaging Workshop will take place on 16-20 October 2023
As in the last two years, aspects of preclinical research will thoroughly be presented and discussed, along with hands-on sessions. Selected oncology and disease models, imaging technologies, preclinical laboratory workflows, and end-to-end preclinical study management, will be the main... -
First γ-eye 188Re images at EMIM 2023
Our collaborators from the University of Zurich are presenting at EMIM2023 the poster “Design and Preclinical Evaluation of 188Re-DETA-N-Onartuzumab for Hepatocyte Growth Factor Receptor Theranostics” by Jonas Genz, Simon Klingler, and Jason Holland. We look forward to seeing even more... -
International Women’s Day 2023
BIOEMTECH wants to thank its 15 women, for the miracle work they do every day. Without your minds and hands, patience and persistence, thirst for knowledge and continuous improvement, but also your smiles and sometimes insanity, BIOEMTECH wouldn’t be... -
Lovely SPECT/CT images from BIOEMTECH laboratories.
Lovely SPECT/CT images from BIOEMTECH laboratories were published at Pharmaceutics by Berthold Nock, Theodosia Maina , and their Molecular Radiopharmacy group at INRaSTES NCSR “DEMOKRITOS” and their collaborators at Johannes Gutenberg-Universität Mainz and AIIMS, New Delhi. It was exciting to see that their 111In/177Lu compound... -
Happy to get our preclinical CRO services expanding.
Happy to get our preclinical CRO services expanding, with clinical chemistry tests. Analysis of markers in body fluids (such as blood, serum, or plasma), is a crucial component in the detection, treatment, and management of diseases and health disorders... -
BIOEMTECH participated at Innovent Forum between 10 and 11 February weekend in Larissa as an exhibitor
Our co-founder Panagiotis Papadimitroulas with our software team members Valentina Paneta and Vassilis Eleftheriadis was there to present our machine learning and artificial intelligence tools and indicative health applications like radiomics and dosimetry. Our application specialist Sofia Lagoumtzi was there too, to present the “eyes”, our unique molecular imaging systems, and also our CRO services for preclinical testing... -
The INFORM 1 Day Seminar “Advanced Computational Techniques for Oncology: Towards Explainable Artificial Intelligence”
We are pleased to announce that the Seminar’s material, including video presentations, can be downloaded at: https://lnkd.in/dVWmqS2u. Thanks to all the participants for the fruitful discussions and all the experts from LaTIM and University of Warsaw for their inspiring talks. More training events... -
New paper from our US collaborators Viewpoint Molecular Targeting, Inc., who use BIOEMTECH gamma-eye to in vivo image [203Pb]Pb-PSC-PEG-T and [212Pb]Pb-PSC-PEG-T in mice.
Great images that show the accumulation on the tumors at 3h and 24h post administration, confirmed by biodistribution data at 24h. We are glad that our technology makes possible the in vivo imaging of the theragnostic pair 203Pb/212Pb, offering...